Chadchankar, Heramb

English

UEF Electronic Publications

{alpha}-synuclein and its A30P mutant affect actin cytoskeletal structure and dynamics. Molecular biology of the cell

6-Hydroxydopamine lesions of the nucleus accumbens, but not of the caudate nucleus, attenuate enhanced responding with reward-related stimuli produced by intra-accumbens d-amphetamine.

A & Shippenberg TS. D2 receptors regulate dopamine transporter function via an extracellular signal-regulated kinases 1 and 2-dependent and phosphoinositide 3 kinase-independent mechanism.

A broken alpha-helix in folded alpha-Synuclein.

A common neurobiology for pain and pleasure.

A fluorimetric method for the determination of dopamine (3-hydroxytyramine).

A hydrophobic stretch of 12 amino acid residues in the middle of alpha-synuclein is essential for filament assembly.

a member of the synuclein family, influences neurofilament network integrity.

A new brain-specific 14-kDa protein is a phosphoprotein. Its complete amino acid sequence and evidence for phosphorylation.

A new link between pesticides and Parkinson's disease.

A new technique for measuring the temporal characteristics of the carbon fibre microelectrodes in in vivo voltammetry at millisecond time intervals.

A peptide motif consisting of glycine, alanine, and valine is required for the fibrillization and cytotoxicity of human alpha-synuclein.

A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by

A psychomotor stimulant theory of addiction. Psychological review.

A review of the clinical pharmacology of methamphetamine. Addiction (Abingdon,

A role for alpha-synuclein in the regulation of dopamine biosynthesis.

A role for presynaptic mechanisms in the actions of nomifensine and haloperidol.

A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigra.

Abdipranoto A & Vissel B. Functional heterogeneity at dopamine release sites.

Abnormal compartmentalization of norepinephrine in mouse dentate gyrus in alpha-synuclein knockout and A30P transgenic mice.

Absence of alpha-synuclein affects dopamine metabolism and synaptic markers in the striatum of aging mice.

Academic Performance, and Stimulant Prescribing for ADHD: A Nationwide Cohort Study.

Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease.

Accelerated oligomerization by Parkinson's disease linked alpha-synuclein mutants. Annals of the New York Academy of Sciences 2000b;920:42-45.

Accommodation of rat nigrostriatal dopamine neurones to high frequency electrical stimulation of the median forebrain bundle: in vivo voltammetric data.

Actions of 6-hydroxydopamine quinones on catecholamine neurons.

Activity-dependent modulation of the rate at which synaptic vesicles become available to undergo exocytosis.

Activity-related redistribution of presynaptic proteins at the active zone.

Adolescent exposure to methylphenidate alters the activity of rat midbrain dopamine neurons.

Affective bias and response modulation following tyrosine depletion in healthy adults.

Age-related decline in striatal dopamine content and motor performance occurs in the absence of nigral cell loss in a genetic mouse model of Parkinson's disease.

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease.

Alpha synuclein protein levels are increased in serum from recently abstinent cocaine abusers. Drug and alcohol dependence

alpha-Synuclein and dopamine at the crossroads of Parkinson's disease. Trends in neurosciences

Alpha-synuclein and heroin craving in opiate-dependent patients on injectable heroin maintenance.

alpha-Synuclein binds the K(ATP) channel at insulin-secretory granules and inhibits insulin secretion. American journal of physiology.Endocrinology and metabolism

alpha-synuclein binds to Tau and stimulates the protein kinase Acatalyzed tau phosphorylation of serine residues 262 and 356. The Journal of biological chemistry 1999;274:25481-25489. 78

Alpha-synuclein dysfunction in Lewy body diseases. Movement disorders:

Alpha-synuclein expression in substantia nigra and cortex in Parkinson's disease. Movement disorders: official journal of the Movement Disorder Society

alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies.

Alpha-synuclein in Lewy bodies.

Alpha-synuclein in the nucleus accumbens induces changes in cocaine behaviour in rats.

Alpha-synuclein induces hyperphosphorylation of Tau in the MPTP model of parkinsonism. The FASEB journal: official publication of the Federation of American Societies for Experimental Biology

Alpha-synuclein inhibits aromatic amino acid decarboxylase activity in dopaminergic cells.

Alpha-synuclein is localized in a subpopulation of rat brain synaptic vesicles.

Alpha-synuclein locus duplication as a cause of familial Parkinson's disease.

alpha-Synuclein locus triplication causes Parkinson's disease.

Alpha-synuclein mRNA levels correspond to beck depression inventory scores in females with eating disorders.

Alpha-Synuclein occurs in lipid-rich high molecular weight complexes, binds fatty acids, and shows homology to the fatty acid-binding proteins.

Alpha-synuclein overexpression in PC12 and chromaffin cells impairs catecholamine release by interfering with a late step in exocytosis.

Alpha-synuclein overexpression increases cytosolic catecholamine concentration.

Alpha-synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease.

alpha-Synuclein protects against oxidative stress via inactivation of the c-Jun N-terminal kinase stress-signaling pathway in neuronal cells.

Alpha-synuclein protein levels are increased in alcoholic patients and are linked to craving.

Alpha-Synuclein regulation of the dopaminergic transporter: a possible role in the pathogenesis of Parkinson's disease.

Alpha-synuclein structure, posttranslational modification and alternative splicing as aggregation enhancers.

Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP.

Alpha-synuclein, especially the Parkinson's diseaseassociated mutants, forms pore-like annular and tubular protofibrils.

alphaSynuclein expression in rat substantia nigra suppresses phospholipase D2 toxicity and nigral neurodegeneration. Molecular therapy: the journal of the

alphaSynuclein gene haplotypes are associated with Parkinson's disease. Human molecular genetics

Alteration in alpha-synuclein mRNA expression in Parkinson's disease. Movement disorders: official journal of the Movement Disorder Society

Altered dopamine release and uptake kinetics in mice lacking D2 receptors.

Altered neurocircuitry in the dopamine transporter knockout mouse brain. PloS one 2010;5:e11506.

Alternative sulfonylurea receptor expression defines metabolic sensitivity of K-ATP channels in dopaminergic midbrain neurons. The EMBO journal 1999;18:833-846.

Amphetamine and other psychostimulants reduce pH gradients in midbrain dopaminergic neurons and chromaffin granules: a mechanism of action.

Amphetamine augments vesicular dopamine release in the dorsal and ventral striatum through different mechanisms.

Amphetamine exposure enhances habit formation.

An inverse correlation between the apparent rate of dopamine clearance and tonic autoinhibition in subdomains of the rat striatum: a possible role of transporter-mediated dopamine efflux.

and decision making: theoretical comment on Bardgett et al.

Angulo A & Cuenca N. Alpha synuclein gene expression profile in the retina of vertebrates.

Application of the glyoxylic acid method to vibratome sections for the improved visualization of central catecholamine neurons.

Ascorbic acid and the behavioral response to haloperidol: implications for the action of antipsychotic drugs.

Association study of a SNAP-25 microsatellite and attention deficit hyperactivity disorder.

ATP-driven H+ pumping into intracellular organelles.

Attenuation of dopamine transporter activity by alpha-synuclein.

Attenuation of the norepinephrine transporter activity and trafficking via interactions with alphasynuclein.

Augmentation is a potentiation of the exocytotic process.

Aversive stimuli alter ventral tegmental area dopamine neuron activity via a common action in the ventral hippocampus.

Aversive stimuli differentially modulate real-time dopamine transmission dynamics within the nucleus accumbens core and shell.

Aversive stimulus differentially triggers subsecond dopamine release in reward regions.

behavioral, physiologic, and neurodevelopmental changes in mice deficient in monoamine oxidase A or B.

Behavioural and neurochemical response of alpha-synuclein A30P transgenic mice to the effects of LDOPA.

beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease.

Binding of bromine-substituted analogs of methylphenidate to monoamine transporters. European journal of pharmacology 1994;264:177-182. 83

Biochemical pathophysiology of Parkinson's disease.

Björklund A & Divac I. Organization of catecholamine neurons projecting to the frontal cortex in the rat.

Björklund A & Divac I. Organization of mesencephalic dopamine neurons projecting to neocortex and septum.

Björklund A & Divac I. Subcortical afferents to the prefrontal cortex: organization of mesencephalic dopaminergic and mediodorsal thalamic projections.

Bonci A & Malenka RC. Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons.

Bonci A & Palmiter RD. Activation of dopamine neurons is critical for aversive conditioning and prevention of generalized anxiety.

Brain reward in the absence of alpha-synuclein.

Brecha N & Edwards RH. Differential expression of two vesicular monoamine transporters.

Calcium- and activity-dependent synaptic plasticity. Current opinion in neurobiology 1999;9:305-313.

Cannabinoids enhance subsecond dopamine release in the nucleus accumbens of awake rats.

Carbon-fiber microelectrodes modified with 4-sulfobenzene have increased sensitivity and selectivity for catecholamines.

Catechol Omethyltransferase val158-met genotype and individual variation in the brain response to amphetamine.

Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacological Reviews

Catecholamine innervation of the basal forebrain. III. Olfactory bulb, anterior olfactory nuclei, olfactory tubercle and piriform cortex. The Journal of comparative neurology

Catecholamine innervation of the basal forebrain. IV. Topography of the dopamine projection to the basal forebrain and neostriatum. The Journal of comparative neurology

Catecholamine reuptake and storage.

Role of alpha-synuclein in the regulation of dopamine neurotransmission in the striatum

http://epublications.uef.fi/pub/urn_isbn_978-952-61-1184-1/urn_isbn_978-952-61-1184-1.pdf

Role of alpha-synuclein in the regulation of dopamine neurotransmission in the striatum

Abstract

Similar works

Full text

Available Versions

UEF Electronic Publications